Evolution of the E2 region of hepatitis C virus in an infant infected by mother‐to‐infant transmission

Giovanni Sitia(Vita-Salute San Raffaele University), Giulia Morsica(Vita-Salute San Raffaele University), K. Perackis(University of Milan), C Bianchí(University of Milan), Roberto Novati, Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Adriano Lazzarin(Vita-Salute San Raffaele University), Maria Stella De Mitri(University of Bologna), D. Cella(University of Milan)
Journal of Medical Virology
July 13, 2001
10.1002/jmv.1074
Cited by 9

Related Papers

Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
|The Lancet|2009|620
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV
|The Lancet|1992|393
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
Human Papillomavirus Infection and Associated Cervical Disease in Human Immunodeficiency Virus–Infected Women: Effect of Highly Active Antiretroviral Therapy
|The Journal of Infectious Diseases|2001|173